UBS O'Connor’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Buy |
13,297
+12,324
| +1,267% | +$2.29M | 0.13% | 123 |
|
|
2025
Q1 | $204K | Sell |
973
-6,515
| -87% | -$1.37M | 0.01% | 222 |
|
|
2024
Q4 | $1.33M | Buy |
7,488
+6,342
| +553% | +$1.13M | 0.04% | 202 |
|
|
2024
Q3 | $226K | Sell |
1,146
-12,049
| -91% | -$2.38M | 0.01% | 358 |
|
|
2024
Q2 | $2.26M | Buy |
13,195
+12,057
| +1,059% | +$2.07M | 0.06% | 173 |
|
|
2024
Q1 | $207K | Sell |
1,138
-13,583
| -92% | -$2.47M | 0.01% | 375 |
|
|
2023
Q4 | $2.28M | Sell |
14,721
-3,179
| -18% | -$493K | 0.07% | 154 |
|
|
2023
Q3 | $2.67M | Sell |
17,900
-23,700
| -57% | -$3.53M | 0.05% | 190 |
|
|
2023
Q2 | $5.6M | Buy |
41,600
+25,818
| +164% | +$3.48M | 0.12% | 101 |
|
|
2023
Q1 | $2.52M | Buy |
+15,782
| New | +$2.52M | 0.06% | 231 |
|
|
2022
Q4 | – | Sell |
-10,402
| Closed | -$1.4M | – | 12 |
|
|
2022
Q3 | $1.4M | Buy |
+10,402
| New | +$1.4M | 0.02% | 695 |
|
|
2015
Q3 | – | Sell |
-3,798
| Closed | -$255K | – | 451 |
|
|
2015
Q2 | $255K | Buy |
+3,798
| New | +$255K | ﹤0.01% | 665 |
|